收入280亿！恒瑞医药，打赢“翻身仗”

创新药的春天，已经到来。恒瑞医药披露了2024年的财务报告，财报显示，全年实现营收279.85亿，同比增长22.63%；实现归母净利润63.37亿，同比激增47.28%。经过了三年的转型后，随着创新药业务占比大幅提升，恒瑞医药已经走出了仿制药集采的困境。 $恒瑞医药(600276)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":427388413374920,"tweetId":"427388413374920","gmtCreate":1745366570661,"gmtModify":1745370974831,"author":{"id":3570515415388899,"idStr":"3570515415388899","authorId":3570515415388899,"authorIdStr":"3570515415388899","name":"侃见财经","avatar":"https://static.tigerbbs.com/58a85251003e9d3ca730ab71b7738ce8","vip":6,"userType":6,"introduction":"侃见财经官方账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3070,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[{"img":"https://static.tigerbbs.com/247de0c9a900b023810ba948116c9a7e"}],"title":"收入280亿！恒瑞医药，打赢“翻身仗”","html":"<html><head></head><body>创新药的春天，已经到来。恒瑞医药披露了2024年的财务报告，财报显示，全年实现营收279.85亿，同比增长22.63%；实现归母净利润63.37亿，同比激增47.28%。经过了三年的转型后，随着创新药业务占比大幅提升，恒瑞医药已经走出了仿制药集采的困境。 <a href=\"https://laohu8.com/S/600276\">$恒瑞医药(600276)$</a>\n<video poster=\"https://static.tigerbbs.com/247de0c9a900b023810ba948116c9a7e\" tg-width=\"1280\" tg-height=\"720\" class=\"ql-video\" controls=\"true\" controlslist=\"nodownload\" playsinline=\"true\" webkit-playsinline=\"true\">\n <source src=\"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/7d1063901397757910523668624/WS7WiKjMat4A.mp4\">\n</video>\n</body></html>","htmlText":"<html><head></head><body>创新药的春天，已经到来。恒瑞医药披露了2024年的财务报告，财报显示，全年实现营收279.85亿，同比增长22.63%；实现归母净利润63.37亿，同比激增47.28%。经过了三年的转型后，随着创新药业务占比大幅提升，恒瑞医药已经走出了仿制药集采的困境。 <a href=\"https://laohu8.com/S/600276\">$恒瑞医药(600276)$</a>\n<video poster=\"https://static.tigerbbs.com/247de0c9a900b023810ba948116c9a7e\" tg-width=\"1280\" tg-height=\"720\" class=\"ql-video\" controls=\"true\" controlslist=\"nodownload\" playsinline=\"true\" webkit-playsinline=\"true\">\n <source src=\"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/7d1063901397757910523668624/WS7WiKjMat4A.mp4\">\n</video>\n</body></html>","text":"创新药的春天，已经到来。恒瑞医药披露了2024年的财务报告，财报显示，全年实现营收279.85亿，同比增长22.63%；实现归母净利润63.37亿，同比激增47.28%。经过了三年的转型后，随着创新药业务占比大幅提升，恒瑞医药已经走出了仿制药集采的困境。 $恒瑞医药(600276)$","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/427388413374920","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"198dc6b181ae417b9a5c43421a43e9a3","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/7d1063901397757910523668624/WS7WiKjMat4A.mp4","poster":"https://static.tigerbbs.com/247de0c9a900b023810ba948116c9a7e","desc":""},"viewCount":290,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["600276"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":234,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/427388413374920"}